X
Limited access to cancer biomarker testing in Europe, report finds
https://pharmaphorum.com/news/limited-access-to-biomarker-testing-in-europe-report-finds/
EFPIA
Despite ‘no pick and mix’ warning, pharma’s Brexit planners still hope for deal
The chairman of a pan-European pharma group says he is still optimistic that a Brexit deal can be struck, despite the head of the European Council rejecting British plans for future alignment.
Is Europe ready for a single health technology assessment?
The EU has unveiled plans for greater Health Technology Assessment harmonisation this week – and put the potential benefits for life sciences centre stage.
Huge scale of Brexit threat to Europe’s medicines supplies revealed
New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.
FDA takes big step towards manufacturing harmonisation with Europe
FDA agrees to recognise some EU inspections for the first time